Table 5 Toxicity comparison among subgroup Patients characteristics between and BT with or without external beam radiotherapy.
Group | UHF | BT ± EBRT | |||
|---|---|---|---|---|---|
Subgroup (Accumulated incidence at 5-years) (PT NO) | L-UHF | H-UHF | HDR + EBRT | LDR | LDR + EBRT |
(1.2%) | (9.3%) | (1.5%) | (0.3%) | (2.4%) | |
(n = 162) | (n = 91) | (n = 1187) | (n = 411) | (n = 66) | |
(a) Gastrointestinal oxcicity | |||||
L-UHF | – | 0.0281 | 1 | 0.0725 | 1 |
H-UHF | – | - | < 0.001 | < 0.001 | < 0.001 |
HDR + EBRT | – | – | – | 0.0771 | 1 |
LDR | – | – | – | – | 0.0891 |
LDR + EBRT | – | – | – | – | – |
Group | UHF | BT ± EBRT | |||
|---|---|---|---|---|---|
Subgroup (Accumulated incidence at 5-years) (PT NO) | L-UHF | H-UHF | HDR + EBRT | LDR | LDR + EBRT |
(3.0%) | (11.1%) | (13.5%) | (13.5%) | (13.4%) | |
(n = 162) | (n = 91) | (n = 1187) | (n = 411) | (n = 66) | |
(b) Genitourinary toxicity | |||||
L-UHF | – | 0.069 | 0.171 | 0.069 | 0.812 |
H-UHF | – | – | 1 | 1 | 1 |
HDR + EBRT | – | – | – | 1 | 1 |
LDR | – | – | – | – | 1 |
LDR + EBRT | – | – | – | – | – |
